CD8A and leukemia: The idea of defective or diminished leukemia control by CD8+ T-cells was supported by the reduced proliferative capacity and target cell lysis observed in patient blood-derived CD8+ T-cells after T-cell receptor (TCR) engagement ex vivo [9].